BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 53 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $177,000 | -59.3% | 168,203 | -34.2% | 0.07% | -59.6% |
| Q2 2019 | $435,000 | +2.4% | 255,703 | +102.7% | 0.18% | +8.3% |
| Q1 2019 | $425,000 | +30.8% | 126,127 | +13.2% | 0.17% | +10.5% |
| Q4 2018 | $325,000 | -41.5% | 111,427 | +23.4% | 0.15% | -15.0% |
| Q3 2018 | $556,000 | -1.8% | 90,327 | +17.8% | 0.18% | -15.1% |
| Q2 2018 | $566,000 | +27.5% | 76,653 | +13.3% | 0.21% | +15.8% |
| Q1 2018 | $444,000 | -11.9% | 67,653 | +12.8% | 0.18% | -8.5% |
| Q4 2017 | $504,000 | -23.4% | 59,984 | +5.3% | 0.20% | -28.8% |
| Q3 2017 | $658,000 | +182.4% | 56,984 | +185.1% | 0.28% | +189.7% |
| Q2 2017 | $233,000 | +77.9% | 19,984 | +88.8% | 0.10% | +54.0% |
| Q1 2017 | $131,000 | – | 10,584 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 95,215 | $1,297,000 | 1.28% |
| Baker Brothers Advisors | 4,865,647 | $66,270,000 | 0.65% |
| Eventide Asset Management | 250,000 | $3,405,000 | 0.22% |
| MCDANIEL TERRY & CO | 76,112 | $1,037,000 | 0.22% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 82,538 | $1,124,000 | 0.15% |
| QVT Financial LP | 337,923 | $4,603,000 | 0.14% |
| KENNEDY CAPITAL MANAGEMENT LLC | 478,465 | $6,517,000 | 0.11% |
| Vident Investment Advisory, LLC | 47,157 | $642,000 | 0.08% |
| Tekla Capital Management LLC | 60,000 | $817,000 | 0.04% |
| First Eagle Investment Management, LLC | 775,254 | $10,559,000 | 0.03% |